Not Medicare Enrolled

Dr. Guillermo Abesada-Terk, M.D.

Medical Oncology · Stuart, FL
Low-engagement
301 SE OCEAN BLVD, Stuart, FL 34994
7722874061
In practice since 2007 (18 years)
NPI: 1134313273 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abesada-Terk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abesada-Terk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abesada-Terk

Dr. Guillermo Abesada-Terk is a medical oncology in Stuart, FL, with 18 years in practice.

Between the years covered by Open Payments, Dr. Abesada-Terk received a total of $15,099 from 72 pharmaceutical and/or device companies across 881 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abesada-Terk is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $15,099 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$15,099
Total received (2018-2024)
Avg $2,516/year across 6 years
Top 35% in FL for medical oncology
72
Companies
881
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,568 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$531 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16
2022
$1,426
2021
$2,387
2020
$1,999
2019
$4,708
2018
$4,563

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,518
Amgen Inc.
$1,080
E.R. Squibb & Sons, L.L.C.
$958
Novartis Pharmaceuticals Corporation
$955
AstraZeneca Pharmaceuticals LP
$889
Celgene Corporation
$848
PFIZER INC.
$758
Merck Sharp & Dohme Corporation
$632
Bayer HealthCare Pharmaceuticals Inc.
$562
Incyte Corporation
$498
Genentech USA, Inc.
$491
Dova Pharmaceuticals
$392
Astellas Pharma US Inc
$347
GENZYME CORPORATION
$324
Seattle Genetics, Inc.
$255
Clovis Oncology, Inc.
$252
Lilly USA, LLC
$243
EISAI INC.
$242
Daiichi Sankyo Inc.
$218
NanoString Technologies, Inc.
$201
Pharmacyclics LLC, An AbbVie Company
$198
Taiho Oncology, Inc.
$198
Ipsen Biopharmaceuticals, Inc
$192
Seagen Inc.
$181
Takeda Pharmaceuticals U.S.A., Inc.
$175
GlaxoSmithKline, LLC.
$159
JAZZ PHARMACEUTICALS INC.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$155
Gilead Sciences, Inc.
$143
Janssen Scientific Affairs, LLC
$123
Intuitive Surgical, Inc.
$116
Heron Therapeutics, Inc.
$112
Puma Biotechnology, Inc.
$107
Eisai Inc.
$103
TESARO, Inc.
$100
MEDIVATION FIELD SOLUTIONS LLC
$70
PUMA BIOTECHNOLOGY, INC.
$69
AbbVie Inc.
$62
AbbVie, Inc.
$59
ABBVIE INC.
$59
Foundation Medicine, Inc.
$56
EMD Serono, Inc.
$56
Sobi, Inc
$55
Merck Sharp & Dohme LLC
$51
Pharmacyclics LLC, an AbbVie Company
$46
Lexicon Pharmaceuticals, Inc.
$45
Exelixis Inc.
$44
Mylan Institutional Inc.
$42
BeiGene USA, Inc.
$38
Advanced Accelerator Applications
$35
Sirtex Medical Inc
$35
Kyowa Kirin, Inc.
$35
Myriad Genetic Laboratories, Inc.
$28
Shire North American Group Inc
$28
Karyopharm Therapeutics Inc.
$27
Global Blood Therapeutics, Inc.
$24
Regeneron Healthcare Solutions, Inc.
$20
Partner Therapeutics, Inc.
$20
Emmaus Medical, Inc.
$19
Array BioPharma Inc.
$18
Dendreon Pharmaceuticals LLC
$18
Spectrum Pharmaceuticals Inc.
$18
EUSA Pharma (US) LLC
$17
Epizyme, Inc.,
$16
Rigel Pharmaceuticals, Inc.
$15
Aurobindo Pharma USA, Inc.
$15
Alexion Pharmaceuticals, Inc.
$14
Grifols USA, LLC
$14
TOLMAR Pharmaceuticals, Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$13
Fortovia Therapeutics, Inc.
$12
Veracyte, Inc.
$5
Top 3 companies account for 23.6% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BLENREP · BOSULIF · BRUKINSA · Bavencio · Braftovi · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERLEADA · EVENITY · Endari · Enhertu · Erleada · FASLODEX · FOUNDATIONONE · FOUNDATIONONE CDX · Folotyn · Fulphila · GAMMAGARD · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONUREG · OPDIVO · OXBRYTA · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Perjeta · Pomalyst · Prolastin-C · Prolia · REBLOZYL · Revlimid · Rituxan · Rubraca · SANDOSTATIN · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical oncology in Stuart?
Compare medical oncologys in the Stuart area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
4
Per 100K population
2.5
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Abesada-Terk is a medical oncology, and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Abesada-Terk receive payments from pharmaceutical companies?
Yes. Dr. Abesada-Terk received a total of $15,099 from 72 companies across 881 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Abesada-Terk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Medical Oncologys in Stuart
Browse medical oncologys in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →